Mechanism of protection against vascular smoking-induced changes by hormone replacement therapy  by Hellstrom, H.Richard
LETTERS TO THE EDITOR
Mechanism of Protection Against
Vascular Smoking-Induced
Changes by Hormone Replacement Therapy
I read with interest Teede et al.’s (1) report that hormone
replacement therapy (HRT) protects against smoking-induced
changes that favor ischemic heart disease (IHD). The ability of one
agent to prevent IHD (HRT) to protect against another risk factor
(smoking) raises basic issues about the prevention of IHD. The
standard prevention of IHD is based on correcting each operative
risk factor, and the reduction of the risk of smoking by HRT
cannot be explained by such a position.
The recently proposed altered homeostatic theory (2) provides a
mechanism by which HRT can prevent smoking-induced changes.
This hypothesis asserts that the major risk factors favor disease by
the single mechanism of shifting homeostasis inappropriately
toward defensive action (fight/flight), and that the major factors
that prevent IHD reverse this inappropriate shift. Thus, any
preventative measure (such as HRT) can offset any risk factor (such
as smoking). Most individuals have multiple risk factors, and the
ability of single preventative measures, such as HRT, vitamin E,
exercise and low dose aspirin, to reduce the incidence of IHD in
the general population (3) suggests neutralization of diverse risk
factors by single agents.
The altered homeostatic theory was prompted by a study (3)
that showed that major risk factors for IHD, such as stress,
smoking, abnormal lipids, cocaine, diabetes, obesity and homocys-
teine, each express the combination of spasm of resistance vessels
(S-RV) and a thrombotic tendency (S-RV/clotting), and major
preventative factors, such as HRT, the exercised state, vitamin E
and low dose aspirin, each express the combination of vasodilation
of resistance vessels (V-RV) and an antithrombotic tendency
(V-RV/anticlotting).
That major risk and preventative factors express S-RV/clotting
and V-RV/anticlotting, respectively, seems highly consistent with
risk factors operating by one mechanism that is opposed by
preventative factors. Relating these opposing mechanisms to shifts
of homeostasis was based on multiple factors. In brief, the idea of
altered homeostasis was derived from the S-RV concept of
ischemic diseases (3,4), which attributes symptoms to S-RV and
S-RV to altered vascular homeostasis. For the altered homeostatic
theory, alterations of homeostasis were extended to involve other
components of homeostasis, such as the autonomic nervous system
and metabolic processes. In Teede et al.’s study, HRT improved
cholesterol, intimal carotid thickening and systemic arterial com-
pliance, which is consistent with improvement of multiple body
functions.
The idea of an altered homeostatic balance was derived from the
opposition of the autonomic nervous system (sympathetic nervous
system defensive fight/flight vs. parasympathetic nervous system
conservation/withdrawal). The association of sympathetic hyper-
activity with multiple risk factors (2) and the expression of
S-RV/clotting by the alpha-sympathetic nervous system (2) led to
relating the homeostatic shift with inappropriate fight/flight. Also
helpful was Selye’s idea (5) that stress favors disease by prompting
an imbalance of homeostasis with overactivity of the defensive
sympathetic fight/flight response (2). Further, the significant
involvement of inflammation—a basic homeostatic defense mech-
anism—in IHD (2,6,7) strengthened the idea that risk factors shift
homeostasis toward defensive action.
The possibility that any preventative measure operates against
any risk factor has enormous implications for the prevention of
IHD. For example, risk factors that are impossible or difficult to
correct, such as age, smoking, diabetes and obesity, could be
treated by preventative agents, such as HRT (in postmenapausal
women), exercise, vitamin E and low dose aspirin.
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REPLY
The hypothesis generated by Hellstrom in his letter proposes that
estrogen negates the vasoconstrictive and prothrombotic changes
induced by cardiovascular risk factors (CVRFs), including smok-
ing. The concept that CVRFs act by altering the vasoconstrictive/
vasodilative balance toward vasoconstriction, with increased spasm
of resistance vessels, and that estrogen may reverse this balance, is
plausible. However, we suggest that estrogen shifts the balance
between fibrinolytic and coagulation systems toward a prothrom-
botic state.
Smoking impairs endothelial function, alters lipid oxidation and
increases intima medial thickness (IMT) and atherosclerosis.
Alternatively, estrogen reduces the impact of CVRFs, including
smoking, by improvement in lipid profiles, lipoprotein oxidation,
endothelial function, and reduction in coronary intimal plaque and
proliferation of vascular smooth muscle. We have previously
demonstrated that estrogen also negates age-related deterioration
in arterial structure (IMT) and function (1), an effect more marked
in high risk smokers (2). For Hellstrom’s hypothesis to hold true,
the benefits of estrogen directly on the vessel wall would be
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